메뉴 건너뛰기
Journal of Hand Surgery
Volumn 36, Issue 10, 2011, Pages 1708-1710
Recent advances for the management of raynaud phenomenon using botulinum neurotoxin A
Author keywords

[No Author keywords available]
Indexed keywords

ANTIOXIDANT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;
EID: 80053475342     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2011.07.011     Document Type: Review
Times cited : (14)
References (9)
  • 1
    • 0038044576 scopus 로고    scopus 로고
    • Treatment of Raynaud's phenomenon: New insights and developments
    • A.L. Herrick Treatment of Raynaud's phenomenon: new insights and developments Curr Rheumatol Rep 5 2003 168 174
    • (2003) Curr Rheumatol Rep , vol.5 , pp. 168-174
    • Herrick, A.L.1
  • 2
    • 77950839528 scopus 로고    scopus 로고
    • Advances in the treatment of Raynaud's phenomenon
    • T.L. Levien Advances in the treatment of Raynaud's phenomenon Vasc Health Risk Manag 6 2010 167 177
    • (2010) Vasc Health Risk Manag , vol.6 , pp. 167-177
    • Levien, T.L.1
  • 3
    • 60849135398 scopus 로고    scopus 로고
    • Botulinum toxin type A: A treatment option for digital ischemia in patients with Raynaud's phenomenon
    • A. Fregene, D. Ditmars, and A. Siddiqui Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon J Hand Surg 34A 2009 446 452
    • (2009) J Hand Surg , vol.34 A , pp. 446-452
    • Fregene, A.1    Ditmars, D.2    Siddiqui, A.3
  • 4
    • 51349099822 scopus 로고    scopus 로고
    • Improvement in both Raynaud disease and hyperhidrosis in response to botulinum toxin type A treatment
    • I. Kossintseva, and B. Barankin Improvement in both Raynaud disease and hyperhidrosis in response to botulinum toxin type A treatment J Cutan Med Surg 12 2008 189 193
    • (2008) J Cutan Med Surg , vol.12 , pp. 189-193
    • Kossintseva, I.1    Barankin, B.2
  • 5
    • 78649940476 scopus 로고    scopus 로고
    • Botulinum toxin type A in the treatment of Raynaud's phenomenon
    • M.W. Neumeister Botulinum toxin type A in the treatment of Raynaud's phenomenon J Hand Surg 35A 2010 2085 2092
    • (2010) J Hand Surg , vol.35 A , pp. 2085-2092
    • Neumeister, M.W.1
  • 7
    • 2142704322 scopus 로고    scopus 로고
    • Botulinum toxin in the treatment of Raynaud's phenomenon: A pilot study [1]
    • DOI 10.1111/j.1365-2362.2004.01324.x
    • T. Sycha, M. Graninger, E. Auff, and P. Schnider Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study Eur J Clin Invest 34 2004 312 313 (Pubitemid 38553602)
    • (2004) European Journal of Clinical Investigation , vol.34 , Issue.4 , pp. 312-313
    • Sycha, T.1    Graninger, M.2    Auff, E.3    Schnider, P.4
  • 8
    • 33847017781 scopus 로고    scopus 로고
    • Management of vasospastic disorders with botulinum toxin A
    • DOI 10.1097/01.prs.0000244860.00674.57, PII 0000653420070100000032
    • A.L. Van Beek, P.K. Lim, A.J. Gear, and M.R. Pritzker Management of vasospastic disorders with botulinum toxin A Plast Reconstr Surg 119 2007 217 226 (Pubitemid 46360269)
    • (2007) Plastic and Reconstructive Surgery , vol.119 , Issue.1 , pp. 217-226
    • Van Beek, A.L.1    Lim, P.K.2    Gear, A.J.L.3    Pritzker, M.R.4
  • 9
    • 55849151999 scopus 로고    scopus 로고
    • Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: More than twenty years of experience
    • T.M. Seyler, B.P. Smith, D.R. Marker, J. Ma, J. Shen, and T.L. Smith Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience J Bone Joint Surg 90A Suppl 4 2008 133 145
    • (2008) J Bone Joint Surg , vol.90 A , Issue.SUPPL 4 , pp. 133-145
    • Seyler, T.M.1    Smith, B.P.2    Marker, D.R.3    Ma, J.4    Shen, J.5    Smith, T.L.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.